Avacta Therapeutics
  • About
  • Our Science
  • Pipeline
  • News
  • Investors
  • Careers
  • Contact
  • About
    • About Avacta
    • Leadership
    • Scientific Resources
    • Intellectual Property
  • Our Science
    • Our Science
    • 1st Gen
    • 2nd Gen
    • 3rd Gen
    • Partners
    • Clinical trials
  • Pipeline
  • News
  • Investors
    • Investors
    • Key info
    • Corporate Governance
    • Resources
    • Share price
    • RNS News
    • Events
    • Research
  • Careers
    • Job vacancies
    • Benefits of working at Avacta
  • Contact
  • About
    • About Avacta
    • Leadership
    • Scientific Resources
    • Intellectual Property
  • Our Science
    • Our Science
    • 1st Gen
    • 2nd Gen
    • 3rd Gen
    • Partners
    • Clinical trials
  • Pipeline
  • News
  • Investors
    • Investors
    • Key info
    • Corporate Governance
    • Resources
    • Share price
    • RNS News
    • Events
    • Research
  • Careers
    • Job vacancies
    • Benefits of working at Avacta
  • Contact
Home Investors Results Presentations

Results Presentations

  • Preliminary Results for the year ended 31 December 2022 – Presentation video
  • Preliminary Results for the year ended 31 December 2022 – Presentation
  • Preliminary Results for the year ended 31 December 2022
  • Interim Results for the Period Ended 30 June 2022
  • Preliminary Results for the year ending 31 December 2021 – Presentation slides
  • Preliminary Results for the year ending 31 December 2021
  • Interim Results for the 6 Months Period Ending 30th June 2021 – Presentation slides
  • Interim Results for the Period Ended 30 June 2021 and Business Update
  • Preliminary Results for the 12 Months Period Ending 31st December 2020
  • Preliminary Results for the year ending 31 December 2020 – Webinar presentation
  • Preliminary Results for the 12 Months Period Ending 31st December 2020 – Presentation slides
  • Interim Results for the 6 Month Period Ending 30th June 2020
  • Preliminary Results for the 12 Months Period Ending 31st December 2020
  • Interim Results for the 6 Months Period Ending 30th June 2020
  • Prelim Results up to Dec 31st 2019 – Business Update and Outlook Presentation
  • Preliminary Results for the 17-month period ending 31 December 2019
Avacta Therapeutics
  • Diagnostics
  • Terms of Use
  • Terms & Conditions
  • Privacy Policy
  • Intellectual Property
  • Corporate Responsibility
  • Contact Us

Avacta Group plc

Scale Space,  White City
Imperial College Campus
58 Wood Lane
London
W12 7RZ

+44 (0)20 3911 0353

Investor Enquiries

ICR Consilium
85 Gresham Street
London
EC2V 7NQ

 

Email

Twitter | Linkedin

©2025 Avacta Therapeutics. Registered company no. 06605196.